Roche has secured its third antibody-drug conjugate pact of the year, this time agreeing to hand $36 million in upfront payments to Oxford BioTherapeutics. The agreement will also see U.K.-based ...

ZURICH, March 19 (Reuters) - Swiss drugmaker Roche has abandoned global diverse workforce targets and compatriot Novartis is ending its use of diverse panels for U.S. hiring, the latest companies ...

Two of the show's stars, Homelander and Black Noir, are now available in the tactical shooter. The Boys bundle includes Aces as Homelander and Deimos as Black Noir. The bundle is available for ...

The recall affects acne creams from well-known retailers such as Walgreens, La Roche-Posay, and Proactiv. The U.S. Food and Drug Administration (FDA) issued a recall notice on March 11th ...

Some popular skin care products, acne treatments, are being voluntarily recalled because they may contain elevated levels of a chemical that causes cancer, according to a notice posted this week ...

Acne creams from retailers including Walgreens, La Roche-Posay and Proactiv have been voluntarily recalled due to elevated levels of a potentially cancer-causing agent. The U.S. Food and Drug ...

Here's why La Roche-Posay is pulling its Effaclar Duo Acne Spot Treatment from retail shelves. La Roche-Posay is a brand under the L'Oreal Group umbrella. A La Roche-Posay spokesperson confirmed ...

The Food and Drug Administration issued the recall alert Tuesday, saying products from brands like La Roche-Posay, Proactiv, Walgreens and more were being recalled for possible "benzene ...

Roche is meanwhile tying up with Denmark's Zealand Pharma to invent a better GLP-1 weigh-loss drug. Despite these developments, Novo Nordisk stock remains the most attractively valued GLP-1 ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Roche has signed the biggest-ever obesity drug deal with a $5.3bn licensing agreement for a next-generation ...

In addition to Zealand, Novo and AbbVie, Lilly, AstraZeneca and startup Metsera are testing amylin agents. Zealand said Roche plans on developing petrelintide as a single agent and in concert with its ...